左主干病变 PCI 中 IVUS 的指导 作用:是否必需? 钱杰阜外心血管病医院. 术前评价 LM 病变.

Slides:



Advertisements
Similar presentations
TAVOLA ROTONDA Quale Ruolo Clinico e Quale Rimborso per la Franctional Flow Reserve? Correlazioni anatomo-funzionali FFR vs IVUS Luigi Vignali, Parma Bologna.
Advertisements

IVUS Use during Left Main PCI improve Immediate and Long Term Outcome Where is the Evidence? E Murat Tuzcu, MD, FACC Professor of Medicine Vice Chairman.
IVUS-VH & Vulnerable Plaque Jang-Ho Bae, MD., PhD. Heart Center Konyang University Hospital Daejeon City, S. Korea Jang-Ho Bae, MD., PhD. Heart Center.
BIFURCATION LESIONS Dr. Tahsin.N
FFR vs Angiography for Multivessel Evaluation
29th ANNUAL SCIENTIFIC SESSIONS – SCA&I
M.Unverdorben; TCT Problem The treatment of stenoses of small coronary arteries (SVD) and of restenoses after stent deployment (ISR) still show.
Chaim Lotan MD, Yaron Almagor MD, Karel Kuiper MD, M.J. Suttorp MD, William Wijns MD The SICTO Study CYPHER TM Sirolimus-eluting stent in Chronic Total.
As presented by Patrick W. Serruys, MD, PhD, FACC Principal Investigator Thoraxcentre - Erasmus University Rotterdam, The Netherlands PISCES Paclitaxel.
Conventional Stenting Following Predilation and/or Debulking Is Better Than Direct Stenting Myeong-Ki Hong, MD, PhD Asan Medical Center, Seoul, Korea.
Govt. Medical College, Calicut
Multi-vessel disease and intracoronay physiology Combat MI 2009 Kees-joost Botman MD, PhD Catharina hospital Eindhoven Heart Institute The Netherlands.
Technical approach PCI in Small Vessels Washington Cardiology Center Augusto Pichard, L. Satler, K. Kent, R. Waksman, J. Laird, W. Suddath, J. Sharretts,
PCI in Left Main Coronary Bifurcation Disease -Step Mini Crush
CV-1 Everolimus Intravascular Ultrasound (IVUS) Results of Study B253 in De Novo Heart Transplantation Jon A. Kobashigawa, MD Clinical Professor of Medicine/Cardiology.
Disclosures The presenter has no financial involvement with the product or competing products being discussed. The presenter received travel and lodging.
The REALITY Study Results. REALITY Study Design The REALITY Study : Prospective randomized clinical trial to evaluate the safety and efficacy of CYPHER®
Jie Qian National Heart Center & FuWai Hospitall FFR in Diffuse Multivessel Disease.
When I Use IVUS Neal Uren MD FRCP Consultant Cardiologist Royal Infirmary Edinburgh.
Unresolved issues with Drug-eluting Stents Stent Thrombosis Advanced Angioplasty 2007 Dan Blackman Yorkshire Heart Centre.
血管内超声基本知识 浙江大学医学院附属第二医院 心内科 项美香.
Left Main Trifurcation Disease: Early and Long-Term Outcomes Of Percutaneous Coronary Intervention I.Sheiban, A.Gerasimou, F. Sciuto, P.Omedè, G. Biondi.
Pressure Wire Evaluation of the Left Main Stem Dr Phil MacCarthy Consultant Cardiologist King’s Cardiac Centre Left Main 5+ at AA2007, Jan 24 th, 2007.
SIROLIMUS-ELUTING STENTS EFFECTIVELY INHIBIT NEOINTIMAL PROLIFERATION AS COMPARED TO BARE METAL STENTS IN DISEASED SAPHENOUS VEIN GRAFTS: 6-month IVUS.
Which is the role of post-dilation after DES implantation? Enrico Romagnoli 1,2 M.D., Ph.D. 1 Policlinico Casilino, Roma 2 Opedale San Raffaele, Milano.
LM strategy Interventional cardiology dpt Cardiovascular Hospital - Lyon - France Gilles Rioufol MD PhD INSERM U1060 High Tech Marseille, 26 Janvier 2012.
左主干分叉病变治疗策略的选择 Left main bifurcation: what is the best choice? Lei Ge, MD Department of Cardiology, Zhongshan Hospital, Fudan University.
LONG-TERM OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE: INITIAL CLINICAL EXPERIENCE. Graidis Ch. 1,
OCT Assessment of Late Stent Malapposition after DES
Late loss in the choice of DES: Monty Python or the Holy Grail? Azfar Zaman Freeman Hospital, Newcastle-upon-Tyne.
A Prospective, Randomized Trial Evaluating a Paclitaxel-Eluting Balloon in Patients TReated with Endothelial Progenitor Cell CapTuring Stents for De Novo.
LONG-TERM CLINICAL OUTCOMES AFTER REPEAT DRUG-ELUTING STENT IMPLANTATION FOR IN DRUG-ELUTING STENT RESTENOSIS. C. Graidis, D. Dimitriadis, A. Ntatsios,
Direct Stenting is Better (Debate Session) 동아의대 김 무 현.
Baseline Characteristics of the Patient Population (n=525) Colin Berry, et al. Circulation 2007;115:
Is the Decision-Making after Failure of CTO Angioplasty Same? Infarct Related CTO or Non- Infarct Related CTO (Continue the Procedure in Other Vessel or.
Clinical Experience with the Bio Active Stent (BAS) in FINLAND 9 e CFCI Hotel Meridien Etoile Paris, France 10 Octobre 2007 Pasi Karjalainen, MD, PhD.
Lianglong Chen MD PhD FACC
Endeavor 4: A Randomized Comparison of a Zotarolimus- Eluting Stent and a Paclitaxel- Eluting Stent in Patients with Coronary Artery Disease Martin B.
Www. Clinical trial results.org Cypher sirolimus-eluting stent Primary Endpoint:  In-stent and late lumen loss at 9 months (determined by QCA) Secondary.
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki.
ISAR-CABG Objective To compare the efficacy of DES with BMS in a randomized trial powered for clinical events Sample 610 patients with de novo SVG lesions.
Saqib Chowdhary Wythenshawe Hospital STENT THROMBOSIS How Do IVUS & OCT Help.
Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prospective Application of Pre-Defined Intravascular.
Is there any role for intravascular ultrasound in bifurcation lesions? Giuseppe Biondi-Zoccai, MD University of Turin, Turin, Italy.
Left Main PCI: What is Best Practice? Ayman A. Magd, MD FSCAI Board of Trustees of SCAI Board of Trustees of SCAI Professor of Cardiology, Azhar University.
Columbia University Medical Center Cardiovascular Research Foundation New York City, NY Akiko Maehara, MD Use of IVUS Reduces Stent Thrombosis and Myocardial.
Left Main PCI: What is Best Practice? Theodore A Bass, MD FSCAI, FACC President-Elect SCAI Professor of Medicine, University of Florida Medical Director.
Influence of a Pressure Gradient Distal to Implanted Bare-Metal Stent on In-Stent Restenosis After Percutaneous Coronary Intervention Lisette Okkels Jensen,
Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Medical Therapy With Versus Without Revascularization.
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Clinical restenosis after coronary stenting: perspectives.
Prof. Dr. Sigmund Silber, FESC, FACC On behalf of the RESOLUTE
Intravascular ultrasound (IVUS) in percutaneous coronary intervention – summary of key articles While angiography is routinely used for assessment of CAD,
Intravascular ultrasound (IVUS) in the treatment of long and diffuse lesions– summary of key articles Prepared by Radcliffe Cardiology 21 November2016.
Intravascular ultrasound (IVUS) in percutaneous coronary interventions – summary of key articles While angiography is routinely used for assessment of.
IVUS, FFR, OCT- Which Should I Use For PCI?
Clinical Usefulness of Post-Stenting FFR
Bifurcation FFR - Helpful or Wasteful?
Physiological Assessment of Left Main Coronary Artery Disease
When IVUS? When FFR? Assessing Intermediate Lesions
Debate: What Does the Future Hold for the Treatment of Unprotected Left Main Disease? More PCI No More Routine Surgery Ron Waksman, MD, FACC Washington.
OCT-Guided PCI What needs to be done to establish criteria?
The Hidden Cost of Underutilizing PCI for Chronic Total Occlusions
Circ Cardiovasc Interv
Angiography-guided PCI
Bifurcation Disease: Simulation Training Curriculum
Presented at TCT 2006.
Impact of Diabetes Mellitus on Long-term Outcomes in the
Maintenance of Long-Term Clinical Benefit with
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions J. Mehilli, MD Deutsches Herzzentrum Technische.
Presentation transcript:

左主干病变 PCI 中 IVUS 的指导 作用:是否必需? 钱杰阜外心血管病医院

术前评价 LM 病变

造影有局限性 1 、短而没有参照 2 、造影剂反流影响开口判断 3 、层流导致假阳性狭窄 4 、弥漫病变低估支架大小 5 、是否需要使用切割技术 6 、钙化时是否使用旋磨 7 、治疗策略的选择

Comparison between percent stenosis assessment from the quality control (QC) lab vs the clinical site in the CASS Study *area of the square is proportional to the number of cases Of all the coronary segments, the LM has the greatest angiographic assessment variability - I QC lab Clinical Site Fisher et al. Cathet Cardiovasc Diagn 1982;8:565-75

Of all the coronary segments, the LM has the greatest angiographic assessment variability - II Cameron et al. Circulation 1983;68: : 0-24% DS 2: 25-49% DS 3: 50-74% DS 4: 75-89% DS 5:90-100%DS 1: 0-24% DS 2: 25-49% DS 3: 50-74% DS 4: 75-89% DS 5:90-100%DS 0:no difference +1 or -1:1 grade difference +2 or -2:2 grades of difference +3 or -3:3 grades of difference +4 or -4:4 grades of difference 0:no difference +1 or -1:1 grade difference +2 or -2:2 grades of difference +3 or -3:3 grades of difference +4 or -4:4 grades of difference Clinical site vs Quality control Clinical site vs Study Group Study Group vs Quality control Five grades of LM severity # of grades of difference in assessment of LM severity

Lindstaedt et al. Int J Cardiol 2007;120: But surely we are better today! 51 intermediate or equivocal LM lesions were evaluated by FFR and angiography. Four experienced interventional cardiologists visually classified lesions as ‘significant’, ‘not significant’, or ‘unsure.’51 intermediate or equivocal LM lesions were evaluated by FFR and angiography. Four experienced interventional cardiologists visually classified lesions as ‘significant’, ‘not significant’, or ‘unsure.’ The 4 experienced interventional cardiologists achieved correct lesion classification in no more than ~50% of each case regardless of the FFR threshold (≤0.75 or ≤0.80).The 4 experienced interventional cardiologists achieved correct lesion classification in no more than ~50% of each case regardless of the FFR threshold (≤0.75 or ≤0.80). Interobserver variability was large, resulting in unanimous correct lesion classification in only 29%!Interobserver variability was large, resulting in unanimous correct lesion classification in only 29%!

IVUS DS QCA DS p=0.106 Abizaid et al. J Am Coll Cardiol 1999;34: DM and ≥1 untreated vessel (DS>50%) DM and no untreated vessels No DM and ≥1 untreated vessel (DS>50%) No DM and no untreated vessels MACE IVUS MLD (mm) Follow-up of 122 patients with moderate LM disease Independent predictors of months: DM (p=0.004), untreated lesion >50% (p=0.037), and IVUS MLD (p=0.005) – but NOT the plaque burden.

IVUS Predictors of the Events Abizaid et al. JACC 1999;34:707 MLD (mm) CSA(mm 2 ) P= P=0.013

Angiographic Predictors of the Events Abizaid et al. JACC 1999;34:707 MLD (mm) P=NS DS(%) P=NS

Abizaid et al. JACC 1999;34:707

Sano et al. Am J Cardiol 2006;98:99M

MLA=12.5 mm 2 MLD=4 mm MLA=22 mm 2 Baseline FFR=0.85

MLA =4.3 mm 2 MLD= 2.3 mm MLA=9.1 mm 2 MLD=3.4 mm Baseline FFR=0.63

mm

Treatment of LMCA Disease

对角支 支架未贴壁

IVUS-guided DES Implantation 102 Pts with LM Disease Treated with Cypher Stents (Park et al. J Am Coll Cardiol 2005;45:351-6) 53 Pts with LM Disease Treated with Taxus Stents (Erglis et al. J Am Coll Cardiol 2007;50:491-7)

“Optimal” MSA and TLR after DES Implantation (n=595) 8.7 Minimum stent area (mm 2 ) (SJ Park et al. TCT 2007) Malaposition and underexpansion

Independent predictors of mortality in 805 patients with LMCA disease treated with DES (SJ Park et al. TCT 2007) HR 95% CI P Previous CHF Previous CHF Chronic Renal Failure Chronic Renal Failure <0.001 COPD COPD Euroscore ≥ 6 Euroscore ≥ IVUS guidance IVUS guidance

Impact of IVUS Guidance on All- Cause Mortality After LMCA DES Implantation (n=805) (SJ Park et al. TCT 2007) Years after DES implantation Cumulative Incidence ( %) IVUS (n=595) No IVUS (n=210) % 85.6% HR=0.43, p=0.019

Using IVUS, most LM lesions show either insignificant disease or critical disease Using IVUS, most LM lesions show either insignificant disease or critical disease Absolute lumen CSA <6.0mm 2 (or MLD <3.0mm) – independent of plaque burden - is the suggested criterion for a significant LMCA stenosis Absolute lumen CSA <6.0mm 2 (or MLD <3.0mm) – independent of plaque burden - is the suggested criterion for a significant LMCA stenosis Correlates with a LMCA FFR<0.75 Correlates with a LMCA FFR<0.75 Murray’s Law ( LMCA r 3 = LAD r 3 + LCX r 3 ) Murray’s Law ( LMCA r 3 = LAD r 3 + LCX r 3 ) Does not depend on finding a disease-free reference segment Does not depend on finding a disease-free reference segment The best available data indicates that IVUS-guidance during LM DES implantation will reduce 3-year mortality; the final MSA should be >8.5mm 2 to minimize TLR. The best available data indicates that IVUS-guidance during LM DES implantation will reduce 3-year mortality; the final MSA should be >8.5mm 2 to minimize TLR. Summary

Is IVUS guidance necessary for the optimal diagnosis and treatment of left main lesions? Is IVUS guidance necessary for the optimal diagnosis and treatment of left main lesions? Given all of this data, the known limitations of angiography, and the risks of making a mistake, how can you possibly argue otherwise? Given all of this data, the known limitations of angiography, and the risks of making a mistake, how can you possibly argue otherwise? Conclusion

THANK YOU !